Global Pain Relief Medications Market Research Report 2023

Pain Relief Medications Market

According to new survey, global Pain Relief Medications market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Pain Relief Medications market research.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Pain Relief Medications market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Scope of Pain Relief Medications Market Report

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Pain Relief Medications Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Generic Opioids

1.2.3 Branded Opioids

1.2.4 NSAIDs

1.2.5 Others

1.3 Market by Application

1.3.1 Global Pain Relief Medications Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Drugstores

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Pain Relief Medications Market Perspective (2018-2029)

2.2 Pain Relief Medications Growth Trends by Region

2.2.1 Global Pain Relief Medications Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Pain Relief Medications Historic Market Size by Region (2018-2023)

2.2.3 Pain Relief Medications Forecasted Market Size by Region (2024-2029)

2.3 Pain Relief Medications Market Dynamics

2.3.1 Pain Relief Medications Industry Trends

2.3.2 Pain Relief Medications Market Drivers

2.3.3 Pain Relief Medications Market Challenges

2.3.4 Pain Relief Medications Market Restraints

3.1 Global Top Pain Relief Medications Players by Revenue

3.1.1 Global Top Pain Relief Medications Players by Revenue (2018-2023)

3.1.2 Global Pain Relief Medications Revenue Market Share by Players (2018-2023)

3.2 Global Pain Relief Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Pain Relief Medications Revenue

3.4 Global Pain Relief Medications Market Concentration Ratio

3.4.1 Global Pain Relief Medications Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Pain Relief Medications Revenue in 2022

3.5 Pain Relief Medications Key Players Head office and Area Served

3.6 Key Players Pain Relief Medications Product Solution and Service

3.7 Date of Enter into Pain Relief Medications Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Pain Relief Medications Historic Market Size by Type (2018-2023)

4.2 Global Pain Relief Medications Forecasted Market Size by Type (2024-2029)

5.1 Global Pain Relief Medications Historic Market Size by Application (2018-2023)

5.2 Global Pain Relief Medications Forecasted Market Size by Application (2024-2029)

6.1 North America Pain Relief Medications Market Size (2018-2029)

6.2 North America Pain Relief Medications Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Pain Relief Medications Market Size by Country (2018-2023)

6.4 North America Pain Relief Medications Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Pain Relief Medications Market Size (2018-2029)

7.2 Europe Pain Relief Medications Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Pain Relief Medications Market Size by Country (2018-2023)

7.4 Europe Pain Relief Medications Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Pain Relief Medications Market Size (2018-2029)

8.2 Asia-Pacific Pain Relief Medications Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Pain Relief Medications Market Size by Region (2018-2023)

8.4 Asia-Pacific Pain Relief Medications Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Pain Relief Medications Market Size (2018-2029)

9.2 Latin America Pain Relief Medications Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Pain Relief Medications Market Size by Country (2018-2023)

9.4 Latin America Pain Relief Medications Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Pain Relief Medications Market Size (2018-2029)

10.2 Middle East & Africa Pain Relief Medications Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Pain Relief Medications Market Size by Country (2018-2023)

10.4 Middle East & Africa Pain Relief Medications Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Pfizer

11.1.1 Pfizer Company Detail

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Pain Relief Medications Introduction

11.1.4 Pfizer Revenue in Pain Relief Medications Business (2018-2023)

11.1.5 Pfizer Recent Development

11.2 GSK

11.2.1 GSK Company Detail

11.2.2 GSK Business Overview

11.2.3 GSK Pain Relief Medications Introduction

11.2.4 GSK Revenue in Pain Relief Medications Business (2018-2023)

11.2.5 GSK Recent Development

11.3 Grunenthal

11.3.1 Grunenthal Company Detail

11.3.2 Grunenthal Business Overview

11.3.3 Grunenthal Pain Relief Medications Introduction

11.3.4 Grunenthal Revenue in Pain Relief Medications Business (2018-2023)

11.3.5 Grunenthal Recent Development

11.4 Bayer

11.4.1 Bayer Company Detail

11.4.2 Bayer Business Overview

11.4.3 Bayer Pain Relief Medications Introduction

11.4.4 Bayer Revenue in Pain Relief Medications Business (2018-2023)

11.4.5 Bayer Recent Development

11.5 Sanofi

11.5.1 Sanofi Company Detail

11.5.2 Sanofi Business Overview

11.5.3 Sanofi Pain Relief Medications Introduction

11.5.4 Sanofi Revenue in Pain Relief Medications Business (2018-2023)

11.5.5 Sanofi Recent Development

11.6 Eli Lilly

11.6.1 Eli Lilly Company Detail

11.6.2 Eli Lilly Business Overview

11.6.3 Eli Lilly Pain Relief Medications Introduction

11.6.4 Eli Lilly Revenue in Pain Relief Medications Business (2018-2023)

11.6.5 Eli Lilly Recent Development

11.7 AstraZeneca

11.7.1 AstraZeneca Company Detail

11.7.2 AstraZeneca Business Overview

11.7.3 AstraZeneca Pain Relief Medications Introduction

11.7.4 AstraZeneca Revenue in Pain Relief Medications Business (2018-2023)

11.7.5 AstraZeneca Recent Development

11.8 Endo

11.8.1 Endo Company Detail

11.8.2 Endo Business Overview

11.8.3 Endo Pain Relief Medications Introduction

11.8.4 Endo Revenue in Pain Relief Medications Business (2018-2023)

11.8.5 Endo Recent Development

11.9 Merck

11.9.1 Merck Company Detail

11.9.2 Merck Business Overview

11.9.3 Merck Pain Relief Medications Introduction

11.9.4 Merck Revenue in Pain Relief Medications Business (2018-2023)

11.9.5 Merck Recent Development

11.10 Depomed

11.10.1 Depomed Company Detail

11.10.2 Depomed Business Overview

11.10.3 Depomed Pain Relief Medications Introduction

11.10.4 Depomed Revenue in Pain Relief Medications Business (2018-2023)

11.10.5 Depomed Recent Development

11.11 Yunnan Baiyao

11.11.1 Yunnan Baiyao Company Detail

11.11.2 Yunnan Baiyao Business Overview

11.11.3 Yunnan Baiyao Pain Relief Medications Introduction

11.11.4 Yunnan Baiyao Revenue in Pain Relief Medications Business (2018-2023)

11.11.5 Yunnan Baiyao Recent Development

11.12 Teva

11.12.1 Teva Company Detail

11.12.2 Teva Business Overview

11.12.3 Teva Pain Relief Medications Introduction

11.12.4 Teva Revenue in Pain Relief Medications Business (2018-2023)

11.12.5 Teva Recent Development

11.13 J&J

11.13.1 J&J Company Detail

11.13.2 J&J Business Overview

11.13.3 J&J Pain Relief Medications Introduction

11.13.4 J&J Revenue in Pain Relief Medications Business (2018-2023)

11.13.5 J&J Recent Development

11.14 Allergan

11.14.1 Allergan Company Detail

11.14.2 Allergan Business Overview

11.14.3 Allergan Pain Relief Medications Introduction

11.14.4 Allergan Revenue in Pain Relief Medications Business (2018-2023)

11.14.5 Allergan Recent Development

11.15 Purdue

11.15.1 Purdue Company Detail

11.15.2 Purdue Business Overview

11.15.3 Purdue Pain Relief Medications Introduction

11.15.4 Purdue Revenue in Pain Relief Medications Business (2018-2023)

11.15.5 Purdue Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Pain Relief Medications Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Generic Opioids

    Table 3. Key Players of Branded Opioids

    Table 4. Key Players of NSAIDs

    Table 5. Key Players of Others

    Table 6. Global Pain Relief Medications Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global Pain Relief Medications Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 8. Global Pain Relief Medications Market Size by Region (2018-2023) & (US$ Million)

    Table 9. Global Pain Relief Medications Market Share by Region (2018-2023)

    Table 10. Global Pain Relief Medications Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 11. Global Pain Relief Medications Market Share by Region (2024-2029)

    Table 12. Pain Relief Medications Market Trends

    Table 13. Pain Relief Medications Market Drivers

    Table 14. Pain Relief Medications Market Challenges

    Table 15. Pain Relief Medications Market Restraints

    Table 16. Global Pain Relief Medications Revenue by Players (2018-2023) & (US$ Million)

    Table 17. Global Pain Relief Medications Market Share by Players (2018-2023)

    Table 18. Global Top Pain Relief Medications Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pain Relief Medications as of 2022)

    Table 19. Ranking of Global Top Pain Relief Medications Companies by Revenue (US$ Million) in 2022

    Table 20. Global 5 Largest Players Market Share by Pain Relief Medications Revenue (CR5 and HHI) & (2018-2023)

    Table 21. Key Players Headquarters and Area Served

    Table 22. Key Players Pain Relief Medications Product Solution and Service

    Table 23. Date of Enter into Pain Relief Medications Market

    Table 24. Mergers & Acquisitions, Expansion Plans

    Table 25. Global Pain Relief Medications Market Size by Type (2018-2023) & (US$ Million)

    Table 26. Global Pain Relief Medications Revenue Market Share by Type (2018-2023)

    Table 27. Global Pain Relief Medications Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 28. Global Pain Relief Medications Revenue Market Share by Type (2024-2029)

    Table 29. Global Pain Relief Medications Market Size by Application (2018-2023) & (US$ Million)

    Table 30. Global Pain Relief Medications Revenue Market Share by Application (2018-2023)

    Table 31. Global Pain Relief Medications Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 32. Global Pain Relief Medications Revenue Market Share by Application (2024-2029)

    Table 33. North America Pain Relief Medications Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 34. North America Pain Relief Medications Market Size by Country (2018-2023) & (US$ Million)

    Table 35. North America Pain Relief Medications Market Size by Country (2024-2029) & (US$ Million)

    Table 36. Europe Pain Relief Medications Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 37. Europe Pain Relief Medications Market Size by Country (2018-2023) & (US$ Million)

    Table 38. Europe Pain Relief Medications Market Size by Country (2024-2029) & (US$ Million)

    Table 39. Asia-Pacific Pain Relief Medications Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 40. Asia-Pacific Pain Relief Medications Market Size by Region (2018-2023) & (US$ Million)

    Table 41. Asia-Pacific Pain Relief Medications Market Size by Region (2024-2029) & (US$ Million)

    Table 42. Latin America Pain Relief Medications Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 43. Latin America Pain Relief Medications Market Size by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Pain Relief Medications Market Size by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Pain Relief Medications Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 46. Middle East & Africa Pain Relief Medications Market Size by Country (2018-2023) & (US$ Million)

    Table 47. Middle East & Africa Pain Relief Medications Market Size by Country (2024-2029) & (US$ Million)

    Table 48. Pfizer Company Detail

    Table 49. Pfizer Business Overview

    Table 50. Pfizer Pain Relief Medications Product

    Table 51. Pfizer Revenue in Pain Relief Medications Business (2018-2023) & (US$ Million)

    Table 52. Pfizer Recent Development

    Table 53. GSK Company Detail

    Table 54. GSK Business Overview

    Table 55. GSK Pain Relief Medications Product

    Table 56. GSK Revenue in Pain Relief Medications Business (2018-2023) & (US$ Million)

    Table 57. GSK Recent Development

    Table 58. Grunenthal Company Detail

    Table 59. Grunenthal Business Overview

    Table 60. Grunenthal Pain Relief Medications Product

    Table 61. Grunenthal Revenue in Pain Relief Medications Business (2018-2023) & (US$ Million)

    Table 62. Grunenthal Recent Development

    Table 63. Bayer Company Detail

    Table 64. Bayer Business Overview

    Table 65. Bayer Pain Relief Medications Product

    Table 66. Bayer Revenue in Pain Relief Medications Business (2018-2023) & (US$ Million)

    Table 67. Bayer Recent Development

    Table 68. Sanofi Company Detail

    Table 69. Sanofi Business Overview

    Table 70. Sanofi Pain Relief Medications Product

    Table 71. Sanofi Revenue in Pain Relief Medications Business (2018-2023) & (US$ Million)

    Table 72. Sanofi Recent Development

    Table 73. Eli Lilly Company Detail

    Table 74. Eli Lilly Business Overview

    Table 75. Eli Lilly Pain Relief Medications Product

    Table 76. Eli Lilly Revenue in Pain Relief Medications Business (2018-2023) & (US$ Million)

    Table 77. Eli Lilly Recent Development

    Table 78. AstraZeneca Company Detail

    Table 79. AstraZeneca Business Overview

    Table 80. AstraZeneca Pain Relief Medications Product

    Table 81. AstraZeneca Revenue in Pain Relief Medications Business (2018-2023) & (US$ Million)

    Table 82. AstraZeneca Recent Development

    Table 83. Endo Company Detail

    Table 84. Endo Business Overview

    Table 85. Endo Pain Relief Medications Product

    Table 86. Endo Revenue in Pain Relief Medications Business (2018-2023) & (US$ Million)

    Table 87. Endo Recent Development

    Table 88. Merck Company Detail

    Table 89. Merck Business Overview

    Table 90. Merck Pain Relief Medications Product

    Table 91. Merck Revenue in Pain Relief Medications Business (2018-2023) & (US$ Million)

    Table 92. Merck Recent Development

    Table 93. Depomed Company Detail

    Table 94. Depomed Business Overview

    Table 95. Depomed Pain Relief Medications Product

    Table 96. Depomed Revenue in Pain Relief Medications Business (2018-2023) & (US$ Million)

    Table 97. Depomed Recent Development

    Table 98. Yunnan Baiyao Company Detail

    Table 99. Yunnan Baiyao Business Overview

    Table 100. Yunnan Baiyao Pain Relief Medications Product

    Table 101. Yunnan Baiyao Revenue in Pain Relief Medications Business (2018-2023) & (US$ Million)

    Table 102. Yunnan Baiyao Recent Development

    Table 103. Teva Company Detail

    Table 104. Teva Business Overview

    Table 105. Teva Pain Relief Medications Product

    Table 106. Teva Revenue in Pain Relief Medications Business (2018-2023) & (US$ Million)

    Table 107. Teva Recent Development

    Table 108. J&J Company Detail

    Table 109. J&J Business Overview

    Table 110. J&J Pain Relief Medications Product

    Table 111. J&J Revenue in Pain Relief Medications Business (2018-2023) & (US$ Million)

    Table 112. J&J Recent Development

    Table 113. Allergan Company Detail

    Table 114. Allergan Business Overview

    Table 115. Allergan Pain Relief Medications Product

    Table 116. Allergan Revenue in Pain Relief Medications Business (2018-2023) & (US$ Million)

    Table 117. Allergan Recent Development

    Table 118. Purdue Company Detail

    Table 119. Purdue Business Overview

    Table 120. Purdue Pain Relief Medications Product

    Table 121. Purdue Revenue in Pain Relief Medications Business (2018-2023) & (US$ Million)

    Table 122. Purdue Recent Development

    Table 123. Research Programs/Design for This Report

    Table 124. Key Data Information from Secondary Sources

    Table 125. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Pain Relief Medications Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Pain Relief Medications Market Share by Type: 2022 VS 2029

    Figure 3. Generic Opioids Features

    Figure 4. Branded Opioids Features

    Figure 5. NSAIDs Features

    Figure 6. Others Features

    Figure 7. Global Pain Relief Medications Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 8. Global Pain Relief Medications Market Share by Application: 2022 VS 2029

    Figure 9. Hospitals Case Studies

    Figure 10. Clinics Case Studies

    Figure 11. Drugstores Case Studies

    Figure 12. Pain Relief Medications Report Years Considered

    Figure 13. Global Pain Relief Medications Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 14. Global Pain Relief Medications Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 15. Global Pain Relief Medications Market Share by Region: 2022 VS 2029

    Figure 16. Global Pain Relief Medications Market Share by Players in 2022

    Figure 17. Global Top Pain Relief Medications Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pain Relief Medications as of 2022)

    Figure 18. The Top 10 and 5 Players Market Share by Pain Relief Medications Revenue in 2022

    Figure 19. North America Pain Relief Medications Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 20. North America Pain Relief Medications Market Share by Country (2018-2029)

    Figure 21. United States Pain Relief Medications Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Canada Pain Relief Medications Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Europe Pain Relief Medications Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Europe Pain Relief Medications Market Share by Country (2018-2029)

    Figure 25. Germany Pain Relief Medications Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. France Pain Relief Medications Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. U.K. Pain Relief Medications Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Italy Pain Relief Medications Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Russia Pain Relief Medications Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Nordic Countries Pain Relief Medications Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Asia-Pacific Pain Relief Medications Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Asia-Pacific Pain Relief Medications Market Share by Region (2018-2029)

    Figure 33. China Pain Relief Medications Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Japan Pain Relief Medications Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. South Korea Pain Relief Medications Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Southeast Asia Pain Relief Medications Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. India Pain Relief Medications Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Australia Pain Relief Medications Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Latin America Pain Relief Medications Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Latin America Pain Relief Medications Market Share by Country (2018-2029)

    Figure 41. Mexico Pain Relief Medications Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Brazil Pain Relief Medications Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Middle East & Africa Pain Relief Medications Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Middle East & Africa Pain Relief Medications Market Share by Country (2018-2029)

    Figure 45. Turkey Pain Relief Medications Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Saudi Arabia Pain Relief Medications Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Pfizer Revenue Growth Rate in Pain Relief Medications Business (2018-2023)

    Figure 48. GSK Revenue Growth Rate in Pain Relief Medications Business (2018-2023)

    Figure 49. Grunenthal Revenue Growth Rate in Pain Relief Medications Business (2018-2023)

    Figure 50. Bayer Revenue Growth Rate in Pain Relief Medications Business (2018-2023)

    Figure 51. Sanofi Revenue Growth Rate in Pain Relief Medications Business (2018-2023)

    Figure 52. Eli Lilly Revenue Growth Rate in Pain Relief Medications Business (2018-2023)

    Figure 53. AstraZeneca Revenue Growth Rate in Pain Relief Medications Business (2018-2023)

    Figure 54. Endo Revenue Growth Rate in Pain Relief Medications Business (2018-2023)

    Figure 55. Merck Revenue Growth Rate in Pain Relief Medications Business (2018-2023)

    Figure 56. Depomed Revenue Growth Rate in Pain Relief Medications Business (2018-2023)

    Figure 57. Yunnan Baiyao Revenue Growth Rate in Pain Relief Medications Business (2018-2023)

    Figure 58. Teva Revenue Growth Rate in Pain Relief Medications Business (2018-2023)

    Figure 59. J&J Revenue Growth Rate in Pain Relief Medications Business (2018-2023)

    Figure 60. Allergan Revenue Growth Rate in Pain Relief Medications Business (2018-2023)

    Figure 61. Purdue Revenue Growth Rate in Pain Relief Medications Business (2018-2023)

    Figure 62. Bottom-up and Top-down Approaches for This Report

    Figure 63. Data Triangulation

    Figure 64. Key Executives Interviewed